Gregory Guilcher
Positions
Associate Professor
Cumming School of Medicine, Department of Oncology
Associate Professor
Cumming School of Medicine, Department of Pediatrics
Childhood Cancer & Blood Disorders Program Director
Alberta Children's Hospital Research Institute
Child Health & Wellness Researcher
Alberta Children's Hospital Research Institute
Member
Arnie Charbonneau Cancer Institute
Contact information
Web presence
Phone number
Office- research inquiries only: 403.955.7272
For media enquiries, contact
Kelly Johnston
Senior Communications Specialist
Please submit your media request here
Preferred method of communication
Admin Assistant
Karen Fandrey
Email: karen.fandrey@ahs.ca
Office: 403.955.7272
Background
Credentials
FRCPC, Royal College of Physicians and Surgeons of Canada, 2005
FAAP, American Academy of Pediatrics, 2005
DRCPSC in HSCT-Cellular Therapy, Royal College of Physicians and Surgeons of Canada, 2023
Certification in Pediatrics, Royal College of Physicians and Surgeons of Canada, 2005
Certification in Hematology, Royal College of Physicians and Surgeons of Canada, 2007
Certification in Pediatric Hematology/Oncology, Royal College of Physicians and Surgeons of Canada, 2008
Certification in Pediatrics, American Board of Pediatrics, 2005
Certification in Pediatric Hematology/Oncology, American Board of Pediatrics, 2011
Educational Background
B.Sc. Biochemistry, Queen's University, 1997
Doctor of Medicine, Memorial University of Newfoundland, 2001
Postgraduate Certificate Medical Education, University of Dundee, 2011
Fellowship Pediatric Hematology/Oncology, University of British Columbia, 2007
Residency Pediatrics, Memorial University of Newfoundland, 2004
Biography
Chair of the Children’s Oncology Group HCT-CT/Dermatology/Immunology Late Effects Taskforce, Chair of the Royal College Pediatric Hematology/Oncology Examination Committee, Program Director for Childhood Cancer and Blood Disorders for the Alberta Children’s Hospital Research Institute, Co-Chair of the Hemoglobinopathy Working Committee for Cell Therapy Transplant Canada, Pediatric Transplantion and Cellular Therapy Consortium Hemoglobinopathy Steering Committee
Research
Areas of Research
Acute and late toxicities of therapy, including pharmacogenomic testing to predict and prevent toxicity. Immune recovery after childhood cancer therapy.
Dr. Guilcher is a site investigator for several Phase I, II and III studies.
Hematopoietic cell transplantation (HCT) for malignant and non-malignant diseases, with a special interest in sickle cell disease. Chair of the HCT-CT/Immune/Dermatology Late Effects Taskforce for the Children's Oncology Group.
Research interests include acute and late toxicities of childhood cancer therapy and HCT as well as the study of novel low-toxicity approaches to transplant for pediatric non-malignant diseases. Greg is interested in studying family HCT decision-making , neuropsychological outcomes and health economics questions as related to HCT for sickle cell disease. He also has an interest in pediatric HCT donor safety. A career goal is to expand access to HCT for sickle cell disease to low and middle income countries.
Participation in university strategic initiatives
Projects
Co-Principal Investigator of this multi-site international clinical trial using the NIH nonmyeloablative regimen for matched sibling donor HCT in children and adolescents with sickle cell disease.
Co-Principal Investigator of this multi-site clinical trial using daratumumab prior to conditioning with the NIH nonmyeloablative regimen for sickle cell disease when recipients have donor-directed red blood cell antibodies.
Principal Investigator of this international multi-site prospective registry of HCT outcomes for sickle cell disease.
Co-Principal Investigator of this international study comparing outcomes of HCT for sickle cell disease with disease-modifying therapies.
Awards
- Researcher of the Year, Department of Pediatrics, University of Calgary. 2018
- President's Excellence Award- Outstanding Achievement in Innovation and Research, Alberta Health Services. 2018
- Gold Lego Teaching Award, Department of Pediatrics , University of Calgary PGME. 2021
Publications
In the News
- World-first gene therapy for 2 blood disorders — sickle cell and thalassemia — approved. CBC . (2023)
- Two new gene therapies could present possible cure for sickle cell disease, but access is an obstacle. Globe and Mail. (2024)
- Stem cell transplant cures children with sickle cell anemia, says Alberta hospital. CBC. (2016)
- Community support crucial in advancing childhood cancer research. Global Television . (2022)
Are you the profile owner?
Login to edit.